entertainment -WSS

entertainment

author：Wikipedia 2025-09-28 01:40:23 - browse：31794

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

WSS

What to expect at HLTH 2023, the health care industry conference

Some in Scotland's Orkney Islands want to return to Norway after 550 years

Noem? Reynolds? A very early look at the Republican 'veepstakes'

EU climate chief is concerned over the expansion of the coal industry in China

10 states plan to sue EPA over standards for residential wood

Phenylephrine and the overlooked value of the placebo effect

hotspot

entertainment

focus

Peter Hotez and the public health issue of online harassment

1 dead, 9 hurt in July 4th fireworks explosion

DIEP, the 'gold standard' of breast reconstruction, is under threat

Liquid biopsy for lung cancer is launched by Delfi

Medical records are filled with copy

10 states plan to sue EPA over standards for residential wood

Walensky prepares to leave CDC — and Congress — behind

Senate panel eyes new effort on drug shortages

As demand for Covid shots wanes, Moderna seeks its next success

Colorectal cancer study finds potential in overlooked immune cell

knowledge

FDA authorizes Novavax’s updated Covid

Phenylephrine and the overlooked value of the placebo effect

Senate panel eyes new effort on drug shortages

US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

Senate panel eyes new effort on drug shortages

Why Charlie Gard's case is so disturbing to Americans

Wikipedia

knowledge

hotspot

knowledge